Stonehage Fleming Financial Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,000
Closed -$225K 212
2024
Q4
$225K Hold
4,000
0.01% 130
2024
Q3
$272K Hold
4,000
0.01% 122
2024
Q2
$169K Buy
+4,000
New +$220K ﹤0.01% 134
2024
Q1
Sell
-4,000
Closed -$296K 207
2023
Q4
$296K Buy
+4,000
New +$262K 0.01% 114

Other funds holding EXAS

Stonehage Fleming Financial Services's EXAS Position: Q1 2025 in Review

Stonehage Fleming Financial Services sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 4,000 shares — an estimated $225K sold.

Stonehage Fleming Financial Services first reported a position in EXAS in Q4 2023 and held it in 4 quarters. The position peaked at $296K in Q4 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Stonehage Fleming Financial Services reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 4,000 Exact Sciences shares in Q1 2025, an estimated $225K.
  • Stonehage Fleming Financial Services first reported a position in Exact Sciences in Q4 2023 and held it in 4 quarters.
  • Stonehage Fleming Financial Services's Exact Sciences position peaked at $296K in Q4 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Stonehage Fleming Financial Services's 13F filing for Q1 2025, filed 14 May 2025.